Scholarlink

Background <p>The global burden of lower respiratory infections (LRIs) caused by <i>Mycoplasma pneumoniae</i> remains insufficiently quantified. This study provides estimates of global mortality and disability-adjusted life years (DALYs) attributable to <i>Mycoplasma pneumoniae</i>-associated LRIs from 1990 to 2021.</p> Methods <p>Data were obtained from the Global Burden of Disease Study 2021. Estimates of deaths and DALYs due to <i>Mycoplasma pneumoniae</i>-associated LRIs were analyzed by age, sex, geographical region, and Sociodemographic Index (SDI). Age-standardized rates and estimated annual percentage changes (EAPC) were calculated to evaluate trends over time.</p> Results <p>In 2021, <i>Mycoplasma pneumoniae</i>-associated LRIs were responsible for an estimated 58,352.68 deaths (95% UI: 51,553.87–64,628.90) and 2,851,404.72 DALYs (95% UI: 2,417,832.52–3,292,823.59) worldwide. Considerable geographical disparities were observed. Mortality followed a bimodal age distribution, peaking in young children and older adults. In most age groups, males showed higher mortality than females. Low-SDI countries carried a disproportionately higher mortality burden.</p> Conclusions <p>The highly concentrated and inequitable burden of <i>Mycoplasma pneumoniae</i>-associated LRIs presents a major public health challenge. The pronounced disparities across age, sex, SDI levels, and geographical regions underscore the critical need for targeted policies and optimized resource allocation to address this disproportionate burden.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Global, regional, and national burden of lower respiratory infections due to Mycoplasma pneumoniae from 1990 to 2021: analysis of data from the Global Burden of Disease Study 2021

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月30日

查看全文
  • Chang Peng,
  • Jiayu Luo,
  • Ying Li,
  • Chaofeng Tan,
  • Liping Zhou,
  • Yin Liu

摘要

Background

The global burden of lower respiratory infections (LRIs) caused by Mycoplasma pneumoniae remains insufficiently quantified. This study provides estimates of global mortality and disability-adjusted life years (DALYs) attributable to Mycoplasma pneumoniae-associated LRIs from 1990 to 2021.

Methods

Data were obtained from the Global Burden of Disease Study 2021. Estimates of deaths and DALYs due to Mycoplasma pneumoniae-associated LRIs were analyzed by age, sex, geographical region, and Sociodemographic Index (SDI). Age-standardized rates and estimated annual percentage changes (EAPC) were calculated to evaluate trends over time.

Results

In 2021, Mycoplasma pneumoniae-associated LRIs were responsible for an estimated 58,352.68 deaths (95% UI: 51,553.87–64,628.90) and 2,851,404.72 DALYs (95% UI: 2,417,832.52–3,292,823.59) worldwide. Considerable geographical disparities were observed. Mortality followed a bimodal age distribution, peaking in young children and older adults. In most age groups, males showed higher mortality than females. Low-SDI countries carried a disproportionately higher mortality burden.

Conclusions

The highly concentrated and inequitable burden of Mycoplasma pneumoniae-associated LRIs presents a major public health challenge. The pronounced disparities across age, sex, SDI levels, and geographical regions underscore the critical need for targeted policies and optimized resource allocation to address this disproportionate burden.